Inhibitors of histidine decarboxylase decrease basal gastric acid secretion in the rat

Verner S. Westerberg, Jonathan Geiger

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

We examined the ability of two specific inhibitors of histidine decarboxylase, (s)-α-fluoromethylhistidine (FMHd) and (s)-α-fluoromethylhistamine (FMHm), to inhibit basal gastric acid secretion. The two highest doses of FMHd administered, 50 and 100 mg/kg, decreased basal gastric acid secretion and total secretion volume but did not affect intraluminal pH. FMHm decreased gastric acid secretion, raised intraluminal pH, and to a lesserdegree decreased total secretion volume. Neither compound changed the severity of gastric ulcers produced by cold restraint stress.

Original languageEnglish (US)
Pages (from-to)419-422
Number of pages4
JournalPharmacology, Biochemistry and Behavior
Volume28
Issue number3
DOIs
StatePublished - Jan 1 1987

Fingerprint

Histidine Decarboxylase
Gastric Acid
Rats
Acids
Stomach Ulcer

Keywords

  • Gastric acid
  • Gastric ulcers
  • Histidine decarboxylase
  • Inhibitors

ASJC Scopus subject areas

  • Biochemistry
  • Toxicology
  • Pharmacology
  • Clinical Biochemistry
  • Biological Psychiatry
  • Behavioral Neuroscience

Cite this

Inhibitors of histidine decarboxylase decrease basal gastric acid secretion in the rat. / Westerberg, Verner S.; Geiger, Jonathan.

In: Pharmacology, Biochemistry and Behavior, Vol. 28, No. 3, 01.01.1987, p. 419-422.

Research output: Contribution to journalArticle

@article{515be9bc55c54dbba9d1449e4188c789,
title = "Inhibitors of histidine decarboxylase decrease basal gastric acid secretion in the rat",
abstract = "We examined the ability of two specific inhibitors of histidine decarboxylase, (s)-α-fluoromethylhistidine (FMHd) and (s)-α-fluoromethylhistamine (FMHm), to inhibit basal gastric acid secretion. The two highest doses of FMHd administered, 50 and 100 mg/kg, decreased basal gastric acid secretion and total secretion volume but did not affect intraluminal pH. FMHm decreased gastric acid secretion, raised intraluminal pH, and to a lesserdegree decreased total secretion volume. Neither compound changed the severity of gastric ulcers produced by cold restraint stress.",
keywords = "Gastric acid, Gastric ulcers, Histidine decarboxylase, Inhibitors",
author = "Westerberg, {Verner S.} and Jonathan Geiger",
year = "1987",
month = "1",
day = "1",
doi = "10.1016/0091-3057(87)90464-3",
language = "English (US)",
volume = "28",
pages = "419--422",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Inhibitors of histidine decarboxylase decrease basal gastric acid secretion in the rat

AU - Westerberg, Verner S.

AU - Geiger, Jonathan

PY - 1987/1/1

Y1 - 1987/1/1

N2 - We examined the ability of two specific inhibitors of histidine decarboxylase, (s)-α-fluoromethylhistidine (FMHd) and (s)-α-fluoromethylhistamine (FMHm), to inhibit basal gastric acid secretion. The two highest doses of FMHd administered, 50 and 100 mg/kg, decreased basal gastric acid secretion and total secretion volume but did not affect intraluminal pH. FMHm decreased gastric acid secretion, raised intraluminal pH, and to a lesserdegree decreased total secretion volume. Neither compound changed the severity of gastric ulcers produced by cold restraint stress.

AB - We examined the ability of two specific inhibitors of histidine decarboxylase, (s)-α-fluoromethylhistidine (FMHd) and (s)-α-fluoromethylhistamine (FMHm), to inhibit basal gastric acid secretion. The two highest doses of FMHd administered, 50 and 100 mg/kg, decreased basal gastric acid secretion and total secretion volume but did not affect intraluminal pH. FMHm decreased gastric acid secretion, raised intraluminal pH, and to a lesserdegree decreased total secretion volume. Neither compound changed the severity of gastric ulcers produced by cold restraint stress.

KW - Gastric acid

KW - Gastric ulcers

KW - Histidine decarboxylase

KW - Inhibitors

UR - http://www.scopus.com/inward/record.url?scp=0023469708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023469708&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(87)90464-3

DO - 10.1016/0091-3057(87)90464-3

M3 - Article

VL - 28

SP - 419

EP - 422

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 3

ER -